An aspirin a day keeps the MI away (for some)

American Family Physician

Volumn 65, Issue 10, 2002, Pages 2000-2003

  Miser, William F ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Department of Family Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

CHEMOPROPHYLAXIS; EDITORIAL; HEART INFARCTION; HUMAN; PREVENTIVE HEALTH SERVICE; UNITED STATES;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARDIOVASCULAR DISEASES; DRUG ANTAGONISM; HUMANS; IBUPROFEN; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS;

EID: 0037093280     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Aspirin for the primary prevention of cardiovascular events: Recommendations and rationale
2. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients
3. Applying a meta-analysis to daily clinical practice
4. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin
5. Deaths: Preliminary data for 2000
6. The acute myocardial infarction
7. Healthy People 2010: The role of family physicians in addressing health disparities
8. How does physician advice influence patient behavior? Evidence for a priming effect
9. Direct observation of rates of preventive service delivery in community family practice
10. Tobacco cessation counseling among underserved patients: A report from CaReNet
11. Direct observation of health-habit counseling of adolescents
12. National patterns in the treatment of smokers by physicians
13. Tailoring tobacco counseling to the competing demands in the clinical encounter